Hepatobiliary transport mechanism for the cyclopentapeptide endothelin antagonist BQ-123

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 272, Issue 5 35-5, 1997, Pages

  Shin, Ho Chul ^a   Kato, Yukio ^a   Yamada, Tadashi ^a   Niinuma, Kayoko ^a   Hisaka, Akihiro ^b   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Biliary excretion; Canalicular membrane; Canalicular multispecific organic anion transporter; Primary active transport

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL);

ACTIVE TRANSPORT; ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; DRUG EXCRETION; HYPERBILIRUBINEMIA; INTRAHEPATIC BILE DUCT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030957234     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1997.272.5.g979     Document Type: Article

References (31)

1. Adachi, Y., H. Kobayashi, Y. Kurumi, M. Shouji, M. Kitano, and T. Yamamoto. ATP-dependent taurocholate transport by rat liver canalicular membrane vesicles. Hepatology 14: 655-659, 1991.
2. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
3. Cathapermal, S. M., M. L. Foegh, C. S. Rau, and P. W. Ramwell. Disposition and tissue distribution of angiopeptin in the rat. Drug Metab. Dispos. 19: 735-739, 1991.
4. Fernández-Checa, J. C., H. Takikawa, T. Horie, M. Ookhtens, and N. Kaplowitz. Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats. J. Biol. Chem. 267: 1667-1673, 1992.
5. Gores, G. J., L. J. Kost, L. J. Miller, and N. F. RaRusso. Processing of cholecystokinin by isolated liver cells. Am. J. Physiol. 257 (Gastrointest. Liver Physiol. 20): G242-G248, 1989.
6. Hruby, V. J. Design of peptide hormone and neurotransmitter analogues. Trends Pharmacol. Sci. 6: 259-262, 1985.
7. +-independent transport system. J. Clin. Invest. 73: 659-663, 1984.
8. Ishikawa, T., M. Muller, C. Klunemann, T. Schaub, and D. Keppler. ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. J. Biol. Chem. 265: 19279-19286, 1990.
9. Jansen, P. L. M., and R. P. J. Oude Elferink. Defective hepatic anion secretion in mutant TR- rats. In: Hepatic Transport and Bile Secretion: Physiology and Pathophysiology, edited by N. Tavoloni and P. D. Berk. New York: Raven, 1993, p. 721-731.
10. Kobayashi, K., Y. Sogame, H. Hara, and K. Hayashi. Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes. J. Biol. Chem. 265: 7737-7741, 1990.
11. Lemaire, M., M. Azria, R. Dannecker, P. Marbach, A. Schweitzer, and G. Maurer. Disposition of sandostatin, a new synthetic somatostatin analogue, in rats. Drug Metab. Dispos. 17: 699-703, 1989.
12. Meier, P. J. Canalicular membrane transport processes. In: Hepatic Transport and Bile Secretion: Physiology and Pathophysiology, edited by N. Tavoloni and P. D. Berk. New York: Raven, 1993, p. 587-596.
13. Miyauchi, S., Y. Sugiyama, H. Sato, Y. Sawada, T. Iga, and M. Hanauo. Effect of a diffusional barrier to a metabolite across hepatocytes on its kinetics in "enzyme-distributed" models: a computer-aided simulation study. J. Pharmacokin. Biopharm. 15: 399-421, 1987.
14. Muller, M., T. Ishikawa, U. Berger, C. Klunemann, L. Lucka, A. Schreyer, C. Kannicht, W. Reutter, G. Kurz, and D. Keppler. ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110-kDa glycoprotein binding ATP and bile salt. J. Biol. Chem. 266: 18920-18926, 1991.
15. Nakamura, T., A. Hisaka, Y. Sawasaki, Y. Suzuki, T. Fukami, K. Ishikawa, M. Yano, and Y. Sugiyama. Carrier-mediated active transport of BQ-123, a peptidic endothein antagonist, into rat hepatocytes. J. Pharmacol. Exp. Ther. 278: 564-572, 1996.
16. Nishida, T., C. Hardenbrook, Z. Gatmaitan, and I. M. Arias. ATP-dependent organic anion transport system in normal and TR- rat liver canalicular membranes. Am. J. Physiol. 262 (Gastrointest. Liver Physiol. 25): G629-G635, 1992.
17. Nishikibe, M., S. Tsuchida, M. Okada, T. Fukuroda, K. Shimamoto, M. Yano, K. Ishikawa, and F. Ikemoto. Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sci. 52: 717-724, 1993.
18. Pang, K. S., and M. Rowland. Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J. Pharm. Biopharm. 5: 625-653, 1977.
19. 3H-demethylphalloin in isolated rat liver cells. Arch. Toxicol. 44: 127-135, 1980.
20. Sathirakul, K., H. Suzuki, T. Yamada, M. Hanano, and Y. Sugiyama. Multiple transport systems for organic anions across the bile canalicular membrane. J. Pharmacol. Exp. Ther. 268: 65-73, 1994.
21. +-stimulated hydrolysis of adenosine triphosphate. Eur. J. Biochem. 1: 334-343, 1967.
22. Seeberger, A., and K. Ziegler. Hepatocellular uptake of peptides. II. Interactions between hydrophilic linear renin-inhibiting peptides and transport systems for endogenous substrates in liver cells. Biochem. Pharmacol. 45: 917-925, 1993.
23. Shimamura, H., H. Suzuki, M. Hanano, A. Suzuki, O. Tagaya, T. Horie, and Y. Sugiyama. Multiple systems for the biliary excretion of organic anions in rats: liquiritigenin conjugates as model compounds. J. Pharmacol. Exp. Ther. 271: 370-378, 1994.
24. Simons, T. J. B. Vanadate - a new tool for biologists. Nature 281: 337-338, 1979.
25. Tamai, I., T. Maekawa, and A. Tsuji. Membrane potential-dependent and carrier-mediated transport of cefpiramide, a cephalosporin antibiotic, in canalicular rat liver plasma membrane vesicles. J. Pharmacol. Exp. Ther. 253: 537-253, 1990.
26. Terasaki, T., H. Mizukuchi, C. Itoho, I. Tamai, M. Lemaire, and A. Tsuji. Hepatic uptake of octreotide, a long-acting somatostatin analogue, via a bile acid transport system. Pharm. Res. 12: 11-16, 1995.
27. Watanabe, T., H. Suzuki, Y. Sawada, M. Naito, T. Tsuruo, M. Inaba, M. Hanano, and Y. Sugiyama. Induction of hepatic P-glycoprotein enhances biliary excretion of vincristine in rats. J. Hepatol. 23: 440-448, 1995.
28. Yachi, K., Y. Sugiyama, Y. Sawada, T. Iga, Y. Ikeda, G. Toda, and M. Hanano. Characterization of rose bengal binding to sinusoidal and canalicular plasma membrane from rat liver. Biochim. Biophys. Acta 978: 1-7, 1989.
29. Yamaoka, K., Y. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharm. Dyn. 4: 879-885, 1981.
30. Ziegler, K., C. Kolac, and W. Ising. ATP-dependent transport of the linear renin-inhibiting peptide EMD-51921 by canalicular plasma membrane vesicles of rat liver: evidence of drug-stimulatable ATP-hydrolysis. Biochim. Biophys. Acta 1196: 209-217, 1994.
31. Ziegler, K., W. Lins, and M. Frimmer. Hepatocellular transport of cyclosomatostatins: evidence for a carrier system related to the multispecific bile acid transporter. Biochim. Biophys. Acta 1061: 287-296, 1991.